BAYER AS has a total of 159 patent applications. It decreased the IP activity by 64.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and Israel. Its main competitors in its focus markets pharmaceuticals, chemical engineering and engines, pumps and turbines are CRITITECH INC, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST OBSHCHEJ I EKSPERIMENTALNOJ BIOLOGII and ANTRIABIO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | United States | 12 | |
#3 | Israel | 10 | |
#4 | Canada | 9 | |
#5 | WIPO (World Intellectual Property Organization) | 8 | |
#6 | Republic of Korea | 7 | |
#7 | Uruguay | 7 | |
#8 | Australia | 6 | |
#9 | Brazil | 6 | |
#10 | Hong Kong | 6 | |
#11 | Mexico | 6 | |
#12 | Taiwan | 6 | |
#13 | Argentina | 5 | |
#14 | China | 5 | |
#15 | Serbia | 5 | |
#16 | Singapore | 5 | |
#17 | Chile | 4 | |
#18 | United Kingdom | 4 | |
#19 | Japan | 4 | |
#20 | Peru | 4 | |
#21 | Cuba | 3 | |
#22 | Hungary | 3 | |
#23 | African Regional Industrial Property Organization | 2 | |
#24 | Costa Rica | 2 | |
#25 | Dominican Republic | 2 | |
#26 | Ecuador | 2 | |
#27 | Nicaragua | 2 | |
#28 | Philippines | 2 | |
#29 | Tunisia | 2 | |
#30 | Belgium | 1 | |
#31 | Colombia | 1 | |
#32 | EAPO (Eurasian Patent Organization) | 1 | |
#33 | Morocco | 1 | |
#34 | Slovenia | 1 | |
#35 | Ukraine | 1 | |
#36 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Engines, pumps and turbines | |
#4 | Measurement | |
#5 | Biotechnology | |
#6 | Materials and metallurgy | |
#7 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Cuthbertson Alan | 47 |
#2 | Frenvik Janne Olsen | 38 |
#3 | Ryan Olav B | 32 |
#4 | Karlson Jan Roger | 26 |
#5 | Mantzilas Dimitrios | 24 |
#6 | Østby Judit Tjelmeland | 13 |
#7 | Alan Cuthbertson | 13 |
#8 | Hjellum Gro Elisabeth | 9 |
#9 | Ryan Olav Benjamin | 8 |
#10 | Janne Olsen Frenvik | 7 |
Publication | Filing date | Title |
---|---|---|
WO2021013978A1 | Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer | |
WO2020043617A1 | Combination of pi3k-inhibitors and targeted thorium conjugates | |
US2020016283A1 | Combination therapy comprising a radiopharmaceutical and a dna-repair inhibitor | |
AU2017277463A1 | Radio-pharmaceutical complexes | |
GB201600153D0 | Isotope preparation method | |
GB201600158D0 | Purification method | |
GB201600161D0 | Isotope purification method | |
GB201600154D0 | Isotope preparation method | |
CN107278155A | Radiopharmaceutical complex compound |